5 Results for "

voruciclib

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "voruciclib" in MCE Product Catalog:

Cat. No.: HY-12422
CAS No.: 1000023-04-0
Purity:  99.77%
Target:  

CDK

Research Areas:  

Cancer

Voruciclib is an orally active and selective CDK inhibitor with Ki values of 0.626 nM-9.1 nM. Voruciclib potently blocks CDK9, the transcriptional regulator of MCL-1. Voruciclib represses expression of MCL-1 in multiple models of diffuse large B-cell lymphoma (DLBCL) .
Cat. No.: HY-12422A
CAS No.: 1000023-05-1
Purity:  99.23%
Target:  

CDK

Research Areas:  

Cancer

Voruciclib hydrochloride is an orally active and selective CDK inhibitor with Ki values of 0.626 nM-9.1 nM. Voruciclib hydrochloride potently blocks CDK9, the transcriptional regulator of MCL-1. Voruciclib hydrochloride represses expression of MCL-1 in multiple models of diffuse large B-cell lymphoma (DLBCL) .
Cat. No.: HY-12422B
CAS No.: 2920469-94-7
Purity:  ≥98.0%
Target:  

CDK

Research Areas:  

Cancer

(2S,3R)-Voruciclib hydrochloride is the enantiomer of Voruciclib hydrochloride. Voruciclib is an orally active CDK inhibitor.
Cat. No.: HY-12422C
CAS No.: 1253731-24-6
Target:  

CDK

Research Areas:  

Cancer

rel-(2S,3R)-Voruciclib is the (2S,3R)-enantiomer of Voruciclib. (2S,3R)-Voruciclib is an orally active CDK inhibitor .
Cat. No.: HY-12422E
CAS No.: 1253647-46-9
Target:  

CDK

Research Areas:  

Cancer

rel-(2S,3R)-Voruciclib hydrochloride is the rel-(2S,3R)-enantiomer of Voruciclib. Voruciclib is an orally active CDK inhibitor .